This is of importance, as IP metabolism has been implicated in both the primary characteristics of MASLD/MASH, including hepatic steatosis and inflammation, as well as the secondary characteristics, such as hepatic insulin sensitivity. This evidence concerns the gene INS and fatty liver disease.